Johnston, R L

Defining response to anti-VEGF therapies in neovascular AMD

Amoaku, W. M., Chakravarthy, U., Gale, R., Gavin, M., Ghanchi, F., Gibson, J., Harding, S., Johnston, R. L., Kelly, S., Lotery, A., et al. (2015) · Eye

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 355

The Neovascular Age-Related Macular Degeneration Database

Zarranz-Ventura, J., Liew, G., Johnston, R. L., Xing, W., Akerele, T., McKibbin, M., Downey, L., Natha, S., Chakravarthy, U., Bailey, C., et al. (2014) · Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 103

Second-year visual acuity outcomes of nAMD patients treated with aflibercept: data analysis from the UK aflibercept users group

Almuhtaseb, H., Johnston, R. L., Talks, J. S., & Lotery, A. J. (2017) · Eye

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 33

Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK

Keenan, T. D. L., Kelly, S. P., Sallam, A., Mohamed, Q., Tufail, A., & Johnston, R. L. (2013) · British Journal of Ophthalmology

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 29